2019, Number 5
PDF size: 162.63 Kb.
ABSTRACTThe relationship between cancer and microbes is complex and not entirely known. The objective of this manuscript is to review the scientific evidence on the relationship between the microbiome, cancer and immunotherapy. A non-systematic literature review was done in the databases MEDLINE, COCHRANE, and DATABASE, and articles of greater scientific rigor, mainly reviews or prospective studies/randomized clinical trials published to date (May 2018), were selected. Terms used in the search included: microbiome, microbiota, cancer, immune checkpoint inhibitors, PD-L1, PD-1 and CTLA-4.
Van Puyenbroeck K, Hens N, Coenen S, Michiels B, Beunckens C, Molenberghs G, et al. Efficacy of daily intake of lactobacillus casei shirota on respiratory symptoms and influenza vaccination immune response: A randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am J Clin Nutr. 2012;95(5):1165- 1171.
Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. Evaluation of the immune benefits of two probiotic strains bifidobacterium animalis ssp. Lactis, BB-12(R) and lactobacillus paracasei ssp. Paracasei, l. Casei 431(R) in an influenza vaccination model: A randomised, double-blind, placebo-controlled study. Br J Nutr. 2012;107(6):876-884.
Jespersen L, Tarnow I, Eskesen D, Morberg CM, Michelsen B, Bugel S, et al. Effect of lactobacillus paracasei subsp. Paracasei, l. Casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: A randomized, double-blind, placebo-controlled, parallel-group study. Am J Clin Nutr. 2015;101(6):1188-1196.